 |
Polyethylene glycol-modified uricase |
|---|---|
| Trade Name | Zurase |
| Orphan Indication | Prophylaxis of hyperuricemia in cancer patients prone to develop tumor lysis syndrome during chemotherapy |
| USA Market Approval | USA |
| USA Designation Date | 1999-09-14 00:00:00 |
| Sponsor | EnzymeRx, LLC;17 Arcadian Avenue, Suite 104;Paramus, New Jersey, 07652 |
